China CAS 1296149-13-7 Manufacturers, Suppliers, Factory

We keep on with the principle of "quality initial, service very first, ongoing improvement and innovation to meet the customers" for the administration and "zero defect, zero complaints" as the quality objective. To fantastic our assistance, we give the goods while using the fantastic high quality at the reasonable price for CAS 1296149-13-7,Glucosamine Sulfate Sodium Chloride,Glucosamine Sulfate Sodium Chloride CAS 1296149-13-7,Glucosamine Sulfate Sodium Chloride API,Glucosamine Sulfate Sodium Chloride Pharmaceutical API, For more details, please get hold of us as soon as possible!
CAS 1296149-13-7, As a way to make use of the resource on the expanding information and facts in international trade, we welcome prospects from everywhere on the web and offline. In spite in the top quality products and solutions we offer, effective and satisfying consultation service is supplied by our professional after-sale service group. Solution lists and comprehensive parameters and any other info weil be sent for you timely for the inquiries. So remember to get in touch with us by sending us emails or contact us if you have any concerns about our firm. ou can also get our address info from our web site and come to our enterprise. or a field survey of our solutions. We're confident that we're likely to share mutual results and build solid co-operation relations with our companions in this market. We're looking forward to your inquiries.

Hot Products

  • Betadex Sulfobutyl Ether Sodium for Pharmaceutical Formulation

    Betadex Sulfobutyl Ether Sodium for Pharmaceutical Formulation

    Betadex Sulfobutyl Ether Sodium for Pharmaceutical Formulation
    CAS No.: 182410-00-0
    Appearance: White or nearly white hygroscopic powder
    Executive Standard USP / EP / ChP
    Packaging: 500 g/bag; 1 kg/bag; 10 kg/bag; 10 kg/drum
    Synonyms: SBE-β-CD; Sulfobutyl Ether Beta-Cyclodextrin; Betadex SBE Sodium
    Assay: ≥99%
    Bacterial Endotoxins: ≤10 EU/g
    MOQ: 1 kg
  • Beta Cyclodextrin CAS 7585-39-9

    Beta Cyclodextrin CAS 7585-39-9

    Beta Cyclodextrin CAS 7585-39-9 – Pharmaceutical Raw Material
    CAS: 7585-39-9
    Synonyms: β-Cyclodextrin; Cyclomaltoheptaose; Beta-Cycloamylose; Beta-Cycloheptaamylose; Beta-Dextrin
    Appearance: White to off-white crystalline powder
    Molecular Formula: C₄₂H₇₀O₃₅
    Molecular Weight: 1134.98
    Application: Pharmaceutical excipient development, cyclodextrin derivative production, API solubility enhancement
  • Sulfobutylether Beta Cyclodextrin Sodium Powder

    Sulfobutylether Beta Cyclodextrin Sodium Powder

    Sulfobutylether Beta Cyclodextrin Sodium Powder
    CAS Number: 182410-00-0
    Appearance: White to off-white amorphous powder
    Grade: Injection grade / Pharmaceutical excipient
    Assay: ≥ 99.0% (on anhydrous basis)
    Solubility: Freely soluble in water
    Bacterial Endotoxins: ≤ 10 EU/g
    Executive Standard: USP / EP / ChP
  • Hydroxypropyl Βeta Cyclodextrin powder CAS 128446-35-5

    Hydroxypropyl Βeta Cyclodextrin powder CAS 128446-35-5

    DELI is a professional China DELI Brand Hydroxypropyl Βetadex powder CAS 128446-35-5. An annual output of 500 tons of Hydroxypropyl Βeta Cyclodextrin powder CAS 128446-35-5
  • Betadex Sulfobutyl Ether Sodium Powder Pharmaceutical Excipients

    Betadex Sulfobutyl Ether Sodium Powder Pharmaceutical Excipients

    Betadex Sulfobutyl Ether Sodium Powder Pharmaceutical Excipients
    CAS No.: 182410-00-0
    Standard: EP / USP
    Molecular Formula: C42H70-nO35·(C4H8SO3Na)n
    Specification: 500 g/bag; 1 kg/bag; 10 kg/bag or drum
    Category: Pharmaceutical excipient
    Storage: Sealed, dry preservation
    Shelf Life: 36 months
  • High Quality Hydroxypropyl Cyclodextrin for Pharmaceutical and Cosmetic Applications

    High Quality Hydroxypropyl Cyclodextrin for Pharmaceutical and Cosmetic Applications

    High Quality Hydroxypropyl Cyclodextrin for Pharmaceutical and Cosmetic Applications enhances solubility, stability, and safety for innovative formulations.

Send Inquiry